Skip to content

What is the generic Latisse used for?

5 min read

Generic Latisse, known by its active ingredient bimatoprost, is the only FDA-approved prescription treatment for growing eyelashes that have become sparse or inadequate. This clinically proven ophthalmic solution enhances the length, thickness, and darkness of a person's natural lashes.

Quick Summary

The generic version of Latisse, bimatoprost ophthalmic solution, is used to treat hypotrichosis of the eyelashes, a condition characterized by inadequate lashes. It is a prescription-only medication that helps to increase eyelash growth, making lashes longer, thicker, and darker over time. The active ingredient works by extending the natural hair growth phase of the eyelashes.

Key Points

  • Purpose: Generic Latisse, with its active ingredient bimatoprost, is a prescription medication used to treat hypotrichosis by increasing eyelash length, thickness, and darkness.

  • Active Ingredient: It contains the same active ingredient, bimatoprost 0.03%, as the brand-name Latisse and is considered equally effective.

  • Mechanism: The solution works by extending the active growth phase of the eyelash hair cycle, allowing lashes to grow longer over time.

  • Results and Duration: Users typically see initial results in 8 to 12 weeks, with full effects appearing around 16 weeks. Consistent daily use is required to maintain the results.

  • Side Effects: Potential side effects include temporary eye redness, itching, and eyelid skin darkening. A rare, but permanent, side effect is increased brown pigmentation of the iris.

  • Application: The solution is applied once nightly to the base of the upper eyelashes only, using a single-use sterile applicator to prevent contamination.

  • Off-Label Use: Some dermatologists may prescribe it off-label for eyebrow growth, but its effectiveness and safety for this use are not yet fully confirmed by research.

In This Article

Understanding Generic Latisse: Bimatoprost Ophthalmic Solution

Generic Latisse is the affordable, FDA-approved alternative to the brand-name product, containing the same active ingredient: bimatoprost 0.03%. It is a prescription ophthalmic solution used to treat hypotrichosis of the eyelashes, a condition where eyelashes are sparse, short, or not numerous enough. The treatment's goal is to stimulate the growth of thicker, longer, and darker lashes.

The Discovery and Original Purpose of Bimatoprost

Before its cosmetic application was discovered, the active ingredient bimatoprost was used for another medical purpose entirely. Marketed under the brand name Lumigan, the solution was initially developed and approved to treat glaucoma and ocular hypertension, both conditions characterized by high pressure inside the eye. The longer, thicker eyelashes experienced by patients using Lumigan were noted as an impressive side effect, which led to the development and FDA approval of Latisse specifically for eyelash hypotrichosis in 2008. Generic bimatoprost became available to consumers in 2015.

How Bimatoprost Stimulates Eyelash Growth

As a prostaglandin analog, bimatoprost's exact mechanism for promoting eyelash growth is not fully understood, but it is believed to work by extending the anagen (active growth) phase of the hair growth cycle. By prolonging this phase, more time is allowed for the eyelashes to grow longer and fuller before entering the telogen (resting) phase. Over a period of several weeks, this process leads to more noticeable and abundant lashes.

Proper Application and What to Expect

Consistent daily application is critical for achieving and maintaining the desired results. Most people begin to notice improvements around 8 to 12 weeks, with full results typically visible by 16 weeks. The proper application method is essential to maximize effectiveness and minimize potential side effects. The solution is applied once nightly to the skin at the base of the upper eyelashes using a new, sterile applicator for each eye. Application to the lower lash line is not recommended.

If treatment with generic Latisse is discontinued, the eyelashes will gradually return to their pretreatment appearance over a period of weeks to months.

Comparison: Generic vs. Brand Name vs. OTC Serums

Feature Generic Bimatoprost (Generic Latisse) Brand-Name Latisse Over-the-Counter Serums
Active Ingredient Bimatoprost 0.03% Bimatoprost 0.03% Varies (e.g., peptides, botanicals, or milder prostaglandin analogs)
FDA Approval Yes, FDA-approved for eyelash hypotrichosis Yes, FDA-approved for eyelash hypotrichosis No, lack robust clinical data for eyelash growth
Prescription Required Yes Yes No
Effectiveness Clinically proven for eyelash growth Clinically proven for eyelash growth Often lack clinical proof of significant growth outcomes
Cost Typically more affordable Higher cost Varies widely, may or may not be less expensive

Important Considerations and Side Effects

Like all prescription medications, generic Latisse is not without potential side effects. It's vital for a healthcare provider to determine if the treatment is appropriate for a patient based on their medical history, especially if they have existing eye conditions.

  • Eye and Eyelid Irritation: Common side effects include temporary itching, redness, or dryness of the eyes. Eyelid skin may also experience some temporary irritation.
  • Skin Pigmentation: Darkening of the skin around the eyes where the solution is applied is a possible side effect, but this is usually reversible after discontinuing treatment.
  • Iris Pigmentation: A more serious, though rare, side effect is an increase in the brown pigmentation of the iris (the colored part of the eye). This color change is likely permanent and can lead to a cosmetic difference between the treated and untreated eye. Proper application technique, focusing only on the upper lash line, can help minimize this risk.
  • Unwanted Hair Growth: If the medication repeatedly touches other skin areas, such as the cheek, it can cause hair growth in those spots. Blotting away any excess solution is important to prevent this.
  • Impact on Eye Pressure: It's important to inform your doctor if you are using bimatoprost for eyelash growth while also taking other medications to lower eye pressure for conditions like glaucoma. The effect of combining these treatments needs to be monitored by an ophthalmologist.

Application Best Practices

To ensure both efficacy and safety, follow these application guidelines:

  • Use Sterile Applicators: Always use a new, sterile applicator for each eye to prevent cross-contamination and the spread of infection.
  • Cleanse Your Face: Before applying, wash your face and remove any makeup to ensure the skin at the base of your lashes is clean and dry.
  • Protect Contact Lenses: Remove contact lenses prior to application and wait at least 15 minutes before reinserting them. The preservative in the solution can discolor soft lenses.
  • Apply Correctly: Apply one drop of the solution to the sterile applicator and brush it along the base of the upper lash line only. Do not apply it to the lower lid.
  • Blot Excess Solution: Wipe away any excess solution that runs down the cheek to prevent unwanted hair growth.
  • Maintain Consistency: Incorporate the nightly application into your routine to ensure consistent use, which is key to seeing results.

Conclusion

Generic Latisse, or bimatoprost ophthalmic solution, is an FDA-approved, prescription treatment for hypotrichosis of the eyelashes, proven to increase their length, thickness, and darkness. As the generic version of Latisse, it offers the same active ingredient and effectiveness at a more accessible price point. The medication works by extending the natural hair growth cycle and requires consistent nightly application to the upper lash line for full results, which typically appear within four months. While generally well-tolerated, potential side effects like eye irritation and possible pigmentation changes of the iris necessitate a prescription and professional supervision to ensure safe use. Following proper application techniques is essential for maximizing benefits and minimizing risks.

This content is for informational purposes only and does not constitute medical advice. Consult with a healthcare professional to determine if a generic Latisse prescription is appropriate for you.

Off-Label Use for Eyebrows

Though not FDA-approved for this purpose, some dermatologists prescribe generic Latisse off-label for eyebrow growth. Preliminary studies have shown potential effectiveness in increasing eyebrow density, but more extensive research is needed to confirm its long-term safety and efficacy for this specific application. Using it for eyebrow growth should be done under the supervision of a healthcare provider.

The Role of Prescription and Consultation

Because bimatoprost is a powerful medication with potential side effects, a prescription is required. A consultation with a licensed healthcare provider is necessary to ensure the treatment is safe for your individual health profile, especially if you have pre-existing eye conditions or are on other medications. This professional oversight is a crucial part of the treatment process.

Frequently Asked Questions

The active ingredient in generic Latisse is bimatoprost ophthalmic solution 0.03%. It is the same compound found in the brand-name Latisse.

Yes, both the brand-name Latisse and its generic counterpart require a prescription from a licensed healthcare provider.

Results are gradual and progressive. Most people start to see noticeable growth in 8 to 12 weeks, with full results typically seen after 16 weeks of consistent nightly application.

If you stop using the medication, your eyelashes will gradually return to their original appearance over several weeks to months. Continued use is needed to maintain results.

In rare cases, bimatoprost can increase the brown pigment in the iris, which may be permanent. This is more of a risk when the medication is applied directly to the eye, emphasizing the importance of proper application to the lash line only.

No, generic Latisse should only be applied to the skin at the base of the upper eyelashes. It should not be used on the lower lashes.

Yes, because the generic version contains the exact same FDA-approved active ingredient, bimatoprost 0.03%, it is considered equally effective for promoting eyelash growth.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.